135 related articles for article (PubMed ID: 9674749)
1. Significance of trilineage myelodysplasia in de novo acute myeloid leukaemia during remission rather than at diagnosis.
Tamura S; Takemoto Y; Wada H; Itoh T; Mori A; Saheki K; Okada M; Takatsuka H; Fujimori Y; Okamoto T; Kakishita E
Br J Haematol; 1998 Jun; 101(4):743-8. PubMed ID: 9674749
[TBL] [Abstract][Full Text] [Related]
2. De-novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) and myelodysplastic remission marrow (AML/MRM).
Tamura S; Kanamaru A
Leuk Lymphoma; 1995 Jan; 16(3-4):263-70. PubMed ID: 7719234
[TBL] [Abstract][Full Text] [Related]
3. Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Japan Adult Leukaemia Study Group (JALSG).
Kuriyama K; Tomonaga M; Matsuo T; Kobayashi T; Miwa H; Shirakawa S; Tanimoto M; Adachi K; Emi N; Hiraoka A
Br J Haematol; 1994 Apr; 86(4):767-73. PubMed ID: 7918070
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
Kuriyama K
Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
[TBL] [Abstract][Full Text] [Related]
5. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic relapse of de novo acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation.
Brito-Babapulle F; Catovsky D; Galton DA
Br J Haematol; 1988 Apr; 68(4):411-5. PubMed ID: 3163932
[TBL] [Abstract][Full Text] [Related]
7. Morphological comparison of dysplastic changes between de novo acute myeloid leukemia (AML) with trilineage myelodysplasia and AML developed from de novo myelodysplastic syndromes.
Kuriyama K; Miyazaki Y; Arimura K; Nagai K; Nakamura H; Matsuo T; Tomonaga M
Leuk Res; 1995 Feb; 19(2):121-5. PubMed ID: 7869740
[TBL] [Abstract][Full Text] [Related]
8. [Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)].
Tsukaguchi M; Furukawa Y; Shibano M; Kitani T
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1119-23. PubMed ID: 15272598
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and poor outcomes in patients with de novo AML with trilineage myelodysplasia].
Arimura K; Kuriyama K; Miyazaki Y; Nagai K; Fukushima T; Yoshida S; Moriuchi Y; Momita S; Tomonaga M
Rinsho Ketsueki; 1995 Feb; 36(2):98-105. PubMed ID: 7715091
[TBL] [Abstract][Full Text] [Related]
10. Remission with morphological myelodysplasia in de novo acute myeloid leukaemia: implications for early relapse.
Nagai K; Matsuo T; Atogami S; Moriuchi Y; Yoshida Y; Kuriyama K; Tomonaga M
Br J Haematol; 1992 May; 81(1):33-9. PubMed ID: 1520622
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
12. The significance of trilineage myelodysplasia in de novo acute myeloblastic leukemia: clinical and laboratory features.
Lima CS; Vassalo J; Lorand-Metze I; Bechelli AP; Souza CA
Haematologia (Budap); 1997; 28(2):85-95. PubMed ID: 9283908
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia.
Brito-Babapulle F; Catovsky D; Galton DA
Br J Haematol; 1987 Aug; 66(4):445-50. PubMed ID: 3478074
[TBL] [Abstract][Full Text] [Related]
14. Clonal remissions in acute myeloid leukaemia are commonly associated with features of trilineage myelodysplasia during remission.
Jowitt SN; Liu Yin JA; Saunders MJ; Lucas GS
Br J Haematol; 1993 Dec; 85(4):698-705. PubMed ID: 7918032
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.
Tauro S; Craddock C; Peggs K; Begum G; Mahendra P; Cook G; Marsh J; Milligan D; Goldstone A; Hunter A; Khwaja A; Chopra R; Littlewood T; Peniket A; Parker A; Jackson G; Hale G; Cook M; Russell N; Mackinnon S
J Clin Oncol; 2005 Dec; 23(36):9387-93. PubMed ID: 16314618
[TBL] [Abstract][Full Text] [Related]
16. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
Fujisawa S; Togawa J; Tanaka M; Koharazawa H; Aoba M; Fujita H; Murata T; Kanamori H; Matsuzaki M; Mohri H; Ishigatsubo Y
Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
[TBL] [Abstract][Full Text] [Related]
17. The rate of disease progression predicts the quality of remissions following intensive chemotherapy for myelodysplastic syndromes.
Hirst WJ; Mufti GJ
Leuk Res; 1994 Nov; 18(11):797-804. PubMed ID: 7967705
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation.
Barnard DR; Lange B; Alonzo TA; Buckley J; Kobrinsky JN; Gold S; Neudorf S; Sanders J; Burden L; Woods WG
Blood; 2002 Jul; 100(2):427-34. PubMed ID: 12091332
[TBL] [Abstract][Full Text] [Related]
19. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of micromegakaryocytes in de novo AML].
Kobayashi S; Seki K; Katayama N; Akiba C; Yamamoto T; Sakai K; Yamaguchi M; Maruta A; Noguchi T; Ogawa K
Rinsho Ketsueki; 1993 Mar; 34(3):313-20. PubMed ID: 8479083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
